Drager Infinity Masimo SET SpO2 Smart Pod

Select Accessory

$795.00

Drager Infinity Masimo SET SpO2 Smart Pod

Drager

SKU#: SET1

In stock

$795.00

Detects true events during low perfusion + patient movement

The Infinity Masimo SET SpO2 SmartPod brings the advantages of Masimo’s gold standard pulse oximetry technology and sensors to Infinity patient monitors. Masimo Signal Extraction Technology (SET) read-through motion and low perfusion pulse oximetry is accurate during low perfusion and most types of patient movement – including shivering, combativeness and seizures. As a result, it can help reduce false alarms and detect true alarms in your patients.

Download Masimo SET SPO2 Smart Pod Techsheet

Download Document of Drager Infinity Masimo SET SpO2 Smart Pod

Discount Cardiology ships via the Federal Express Service, which delivers shipments anywhere in the United States -- usually within 2-5 business days -- at low rates. Unless specified, shipping charges are added to each order based on the specific order.

Drager Infinity Masimo SET SpO2 Smart Pod

Supports all patient categories

The Drager Infinity Masimo SET SpO2 SmartPod® supports all types of patient, including adults, pediatrics and neonates.

Provides superior pulse oximetry technology

At Dräger, our focus is on clinical excellence and quality of care. Consistent with that goal, Dräger has performed an analysis of many pulse oximetry technologies, including Masimo SET and current technology from other vendors. Based on this research, we believe that Masimo’s Signal Extraction Technology provides superior SpO2 and pulse rate measurements during challenging monitoring conditions – including patient motion, low peripheral perfusion and other low signal-to-noise situations.

As a result of this superior performance, as documented in Masimo’s peer-reviewed studies located on www.masimo.com, Dräger has selected Masimo as its preferred provider of SpO2 technology. We are investing heavily in the integration of Masimo technology into our vital signs monitors and are confident that this will enhance our products – leading to more satisfied clinical users and ultimately, better treatment for patients.